Clinical Trial Update: Safety and Efficacy of Grazoprevir and Elbasvir for GT1ang GT6 With and Without HIV [Phase 4]

View source ↗

Summary

Phase 4 trial update on the safety and efficacy of grazoprevir and elbasvir for genotype 1 and genotype 6 hepatitis C, with and without HIV, in compensated cirr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Compensated Cirrhosis
• Hepatitis C

Drugs mentioned

• Grazoprevir and Elbasvir (grazoprevir and elbasvir)

Snippet

Sponsor: The HIV Netherlands Australia Thailand Research Collaboration | Conditions: Compensated Cirrhosis | Phase 4 | Status: UNKNOWN